Nothing Special   »   [go: up one dir, main page]

Maggi et al., 2014 - Google Patents

The formation of inflammatory demyelinated lesions in cerebral white matter

Maggi et al., 2014

View HTML
Document ID
2277535793528780571
Author
Maggi P
Macri S
Gaitán M
Leibovitch E
Wholer J
Knight H
Ellis M
Wu T
Silva A
Massacesi L
Jacobson S
Westmoreland S
Reich D
Publication year
Publication venue
Annals of neurology

External Links

Snippet

Objective Vascular permeability and inflammatory demyelination are intimately linked in the brain, but what is their temporal relationship? We aimed to determine the radiological correlates of the earliest tissue changes accompanying demyelination in a primate model of …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
Maggi et al. The formation of inflammatory demyelinated lesions in cerebral white matter
Absinta et al. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis
Hemond et al. Magnetic resonance imaging in multiple sclerosis
Dal-Bianco et al. Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI
Absinta et al. Seven‐tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process
Wang et al. Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice
Rahmanzadeh et al. A new advanced MRI biomarker for remyelinated lesions in multiple sclerosis
Bonnier et al. Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis
Gaitán et al. Evolution of the blood–brain barrier in newly forming multiple sclerosis lesions
Absinta et al. Advanced MRI and staging of multiple sclerosis lesions
Geurts et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology
Zucca et al. Type II focal cortical dysplasia: Ex vivo 7 T magnetic resonance imaging abnormalities and histopathological comparisons
Stankoff et al. Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl‐11C]‐2‐(4′‐methylaminophenyl)‐6‐hydroxybenzothiazole
Solomon et al. “Central vessel sign” on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine
Goodkin et al. A serial study of new MS lesions and the white matter from which they arise
Kassner et al. Abnormalities of the contrast re‐circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast‐enhanced imaging: a possible marker of vascular tortuosity
Makshakov et al. Leptomeningeal contrast enhancement is associated with disability progression and grey matter atrophy in multiple sclerosis
Ou et al. Quantitative magnetization transfer measured pool‐size ratio reflects optic nerve myelin content in ex vivo mice
Steens et al. Selective gray matter damage in neuropsychiatric lupus: a magnetization transfer imaging study
Honce Gray matter pathology in MS: neuroimaging and clinical correlations
Balashov et al. Acute multiple sclerosis lesion: conversion of restricted diffusion due to vasogenic edema
Ter Telgte et al. Histopathology of diffusion-weighted imaging-positive lesions in cerebral amyloid angiopathy
Weise et al. In vivo imaging of stepwise vessel occlusion in cerebral photothrombosis of mice by 19F MRI
Ineichen et al. New prospects for ultra-high-field magnetic resonance imaging in multiple sclerosis
Fellner et al. Magnetic resonance angiography of the carotid arteries using three different techniques: accuracy compared with intraarterial x‐ray angiography and endarterectomy specimens